Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses

26 July 2021 | Monday | News


Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023
Imagesource : tipranks.com

Imagesource : tipranks.com

Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA
(mRNA) therapeutics and vaccines, today announced a new supply agreement with
Taiwan for 20 million doses of Moderna’s COVID-19 vaccine and its updated
variant booster vaccine candidate, if authorized, to begin delivery in 2022
and an additional 15 million doses in 2023. This new supply agreement is in
addition to the prior agreement for 5 million doses in 2021.

“We thank Taiwan for their support in securing this new agreement to supply in
2022 and 2023 our mRNA COVID-19 vaccine and our updated variant booster
candidate, if approved,” said Stéphane Bancel, Moderna’s Chief Executive
Officer. “We remain committed to making our vaccine available around the
world.”

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close